29679372|t|Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
29679372|a|AIM: Neurodegeneration is associated with dysfunction of calcium buffering capacity and thereby sustained cellular and mitochondrial calcium overload. Paraneoplastic cerebellar degeneration (PCD), characterized by progressive Purkinje neurone degeneration following paraneoplastic Yo antibody internalization and binding to cerebellar degeneration-related protein CDR2 and CDR2L, has been linked to intracellular calcium homeostasis imbalance due to calbindin D28k malfunction. Therefore, we hypothesized that Yo antibody internalization affects not only calbindin calcium binding capacity, but also calcium-sensitive mitochondrial-associated signalling, causing mitochondrial calcium overload and thereby Purkinje neurone death. METHODS: Immunohistochemically, we evaluated cerebellar organotypic slice cultures of rat brains after inducing PCD through the application of Yo antibody-positive PCD patient sera or purified antibodies against CDR2 and CDR2L how pharmacologically biased mitochondrial signalling affected PCD pathology. RESULTS: We found that Yo antibody internalization into Purkinje neurons caused depletion of Purkinje neurone calbindin-immunoreactivity, cannabinoid 1 receptor over-activation and alterations in the actions of the mitochondria permeability transition pore (MPTP), voltage-dependent anion channels, reactive oxygen species (ROS) and Na+ /Ca2+ exchangers (NCX). The pathological mechanisms caused by Yo antibody binding to CDR2 or CDR2L differed between the two targets. Yo-CDR2 binding did not alter the mitochondrial calcium retention capacity, cyclophilin D-independent opening of MPTP or activity of NCX. CONCLUSION: These findings suggest that minimizing intracellular calcium overload toxicity either directly with cyclosporin-A or indirectly with cannabidiol or the ROS scavenger butylated hydroxytoluene promotes mitochondrial calcium homeostasis and may therefore be used as future neuroprotective therapy for PCD patients.
29679372	0	38	Paraneoplastic cerebellar degeneration	Disease	MESH:D020362
29679372	73	80	calcium	Chemical	MESH:D002118
29679372	106	123	Neurodegeneration	Disease	MESH:D019636
29679372	158	165	calcium	Chemical	MESH:D002118
29679372	234	250	calcium overload	Disease	MESH:D019190
29679372	252	290	Paraneoplastic cerebellar degeneration	Disease	MESH:D020362
29679372	292	295	PCD	Disease	MESH:D020362
29679372	327	356	Purkinje neurone degeneration	Disease	MESH:D009410
29679372	382	384	Yo	Chemical	-
29679372	425	448	cerebellar degeneration	Disease	MESH:D013132
29679372	514	521	calcium	Chemical	MESH:D002118
29679372	656	665	calbindin	Gene	793
29679372	666	673	calcium	Chemical	MESH:D002118
29679372	701	708	calcium	Chemical	MESH:D002118
29679372	778	794	calcium overload	Disease	MESH:D019190
29679372	816	829	neurone death	Disease	MESH:D009410
29679372	917	920	rat	Species	10116
29679372	943	946	PCD	Disease	MESH:D020362
29679372	974	976	Yo	Chemical	-
29679372	995	998	PCD	Disease	MESH:D020362
29679372	999	1006	patient	Species	9606
29679372	1121	1124	PCD	Disease	MESH:D020362
29679372	1159	1161	Yo	Chemical	-
29679372	1246	1255	calbindin	Gene	83839
29679372	1351	1387	mitochondria permeability transition	Chemical	-
29679372	1435	1458	reactive oxygen species	Chemical	MESH:D017382
29679372	1460	1463	ROS	Chemical	MESH:D017382
29679372	1469	1489	Na+ /Ca2+ exchangers	Gene	29715
29679372	1491	1494	NCX	Gene	29715
29679372	1654	1661	calcium	Chemical	MESH:D002118
29679372	1682	1695	cyclophilin D	Gene	10105
29679372	1739	1742	NCX	Gene	29715
29679372	1809	1825	calcium overload	Disease	MESH:D019190
29679372	1826	1834	toxicity	Disease	MESH:D064420
29679372	1856	1869	cyclosporin-A	Chemical	MESH:D016572
29679372	1889	1900	cannabidiol	Chemical	MESH:D002185
29679372	1908	1911	ROS	Chemical	MESH:D017382
29679372	1922	1946	butylated hydroxytoluene	Chemical	MESH:D002084
29679372	1970	1977	calcium	Chemical	MESH:D002118
29679372	2054	2057	PCD	Disease	MESH:D020362
29679372	2058	2066	patients	Species	9606
29679372	Association	MESH:D002118	MESH:D002185
29679372	Association	MESH:D002118	MESH:D064420
29679372	Association	MESH:D002084	MESH:D002118
29679372	Negative_Correlation	MESH:D002084	MESH:D020362
29679372	Negative_Correlation	MESH:D016572	MESH:D019190
29679372	Negative_Correlation	MESH:D002185	MESH:D020362
29679372	Negative_Correlation	MESH:D016572	MESH:D020362
29679372	Association	MESH:D002118	MESH:D020362
29679372	Association	MESH:D002118	MESH:D019636
29679372	Negative_Correlation	MESH:D002118	MESH:D016572
29679372	Negative_Correlation	MESH:D016572	MESH:D064420
29679372	Negative_Correlation	MESH:D002185	MESH:D064420
29679372	Association	MESH:D002118	793
29679372	Negative_Correlation	MESH:D002084	MESH:D017382
29679372	Negative_Correlation	MESH:D002084	MESH:D019190
29679372	Negative_Correlation	MESH:D002185	MESH:D019190
29679372	Association	MESH:D017382	MESH:D064420

